A2A adenosine receptor antagonists -: future drugs for Parkinson's disease?

被引：52

作者：

Müller, CE ^{[1
]}

机构：

[1] Univ Bonn, Inst Pharmaceut, D-53115 Bonn, Germany

来源：

DRUGS OF THE FUTURE | 2000年 / 25卷 / 10期

关键词：

D O I：

10.1358/dof.2000.025.10.858696

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：1043 / 1052

页数：10

共 106 条

[1] Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative disease [J].

Abbracchio, MP ;

Cattabeni, F .

NEUROPROTECTIVE AGENTS: FOURTH INTERNATIONAL CONFERENCE, 1999, 890 :79-92

[2] Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist [J].

Aoyama, S ;

Kase, H ;

Borrelli, E .

JOURNAL OF NEUROSCIENCE, 2000, 20 (15) :5848-5852

[3] Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives: Potent and selective A(2A) adenosine antagonists [J].

Baraldi, PG ;

Cacciari, B ;

Spalluto, G ;

Villatoro, MJPDIY ;

Zocchi, C ;

Dionisotti, S ;

Ongini, E .

JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (05) :1164-1171

[4]

Baraldi PG, 1995, CURR MED CHEM, V2, P707

[5]

Baraldi PG, 1999, DRUG DEVELOP RES, V46, P126, DOI 10.1002/(SICI)1098-2299(199902)46:2<126::AID-DDR5>3.0.CO

[6]

2-7

[7]

Baraldi PG, 1996, FARMACO, V51, P297

[8]

BRACKETT LE, 1994, BIOCHEM PHARMACOL, V47, P801

[9] ADENOSINE ANTAGONISM BY PURINES, PTERIDINES AND BENZOPTERIDINES IN HUMAN-FIBROBLASTS [J].

BRUNS, RF .

BIOCHEMICAL PHARMACOLOGY, 1981, 30 (04) :325-333

[10] New substituted 9-alkylpurines as adenosine receptor ligands [J].

Camaioni, E ;

Costanzi, S ;

Vittori, S ;

Volpini, R ;

Klotz, KN ;

Cristalli, G .

BIOORGANIC & MEDICINAL CHEMISTRY, 1998, 6 (05) :523-533

← 1 2 3 4 5 6 7 8 9 10 →